MedPath

Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence

Not Applicable
Conditions
Stress Urinary Incontinence
Interventions
Device: Erbium Yag Laser
Behavioral: Pelvic Floor Training
Registration Number
NCT04705285
Lead Sponsor
Pontificia Universidad Catolica de Chile
Brief Summary

This is a pilot study to assess the feasibility and safety to run a randomized controlled trial that compared the effectivity of erbium:yag vaginal laser versus pelvic floor training in women with mild to moderate stress urinary incontinence.

Detailed Description

This pilot study attempts to demonstrated the feasibility and security to run a randomized controlled study that compared the effectivity of erbium:yag laser used vaginally versus pelvic floor training, coached by a physiotherapist expert in pelvic floor disorders.

Patients are going to be randomized to pelvic floor exercises (10 sessions) or erbium:yag laser (2 sessions), and assess the results at 6 and 12 moths later on.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Mild to Moderated Stress Urinary Incontinence
Exclusion Criteria
  • Mixed Urinary incontinence
  • Pelvic organ prolase greater than stage 2
  • Previous surgery for stress urinary incontinence and/or pelvic organ prolapse
  • Severe Stress urinary incontinence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Erbium:Yag LaserErbium Yag LaserPatients allocated to the erbium:yag laser are going to undergo 2 sessions of vaginal laser, separated by one month each other.
Pelvic floor trainingPelvic Floor TrainingPatients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist.
Primary Outcome Measures
NameTimeMethod
Change in quality of lifeThe questionnaire will be applied at baseline, 6 month and 1 year

In order to measure quality of life, we are going to use the International Consultation on Incontinence Questionnaire Short Form (ICQI-SF), validate to spanish and in Chile. A higher score in this scale means a worse outcome for the patient.

Secondary Outcome Measures
NameTimeMethod
Pad testat baseline, 6 month and 1 year

A 24 h Pad test will be applied. The pad will be weighted after 24 h of use and the difference between the dry pad and the wet pad is going to be recorded. A great difference means a worse outcome for the patient.

Trial Locations

Locations (1)

Hospital Clinico de La Florida

🇨🇱

Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath